Geospatial distribution of patients’ residencies by trial participation. (A) Distribution of all patients within Texas. (B) All patients proximate to TMC. (C) Patients with any trial participation. (D) Patients with no trial participation. (E) Patients in noninterventional trials (with overlap). (F) Patients in therapeuric trials.